Science Group Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Science Group de 18.3% y 1.6% respectivamente, mientras que el BPA crecerá en un 18.5% al año.

Información clave

18.3%

Tasa de crecimiento de los beneficios

18.5%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Professional Services	11.5%
Tasa de crecimiento de los ingresos	1.6%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	23 Jul 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

An Intrinsic Calculation For Science Group plc (LON:SAG) Suggests It's 30% Undervalued

Mar 18

Is It Time To Consider Buying Science Group plc (LON:SAG)?

Jun 04

Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet

May 07

Statutory Profit Doesn't Reflect How Good Science Group's (LON:SAG) Earnings Are

Mar 17

Has Science Group plc's (LON:SAG) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Mar 12

Shareholders Of Science Group (LON:SAG) Must Be Happy With Their 172% Total Return

Feb 05

Is Science Group (LON:SAG) Using Too Much Debt?

Dec 14

Previsiones de crecimiento de beneficios e ingresos

AIM:SAG - Estimaciones futuras de los analistas y datos financieros pasados (GBP Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	115	12	19	22	2
12/31/2025	112	11	20	23	2
12/31/2024	109	11	19	23	2
6/30/2024	111	6	10	10	N/A
3/31/2024	112	6	9	9	N/A
12/31/2023	113	6	8	8	N/A
9/30/2023	105	8	11	11	N/A
6/30/2023	98	11	14	14	N/A
3/31/2023	92	11	15	15	N/A
12/31/2022	86	11	15	15	N/A
9/30/2022	86	10	13	16	N/A
6/30/2022	85	10	12	16	N/A
3/31/2022	83	10	10	15	N/A
12/31/2021	81	10	9	14	N/A
9/30/2021	79	10	11	14	N/A
6/30/2021	77	10	13	13	N/A
3/31/2021	76	8	15	15	N/A
12/31/2020	74	7	18	18	N/A
9/30/2020	72	2	16	16	N/A
6/30/2020	71	-2	14	14	N/A
3/31/2020	64	-2	9	10	N/A
12/31/2019	57	-2	5	5	N/A
9/30/2019	52	1	5	6	N/A
6/30/2019	47	4	5	6	N/A
3/31/2019	48	4	5	6	N/A
12/31/2018	49	4	5	6	N/A
9/30/2018	48	4	6	6	N/A
6/30/2018	48	3	7	7	N/A
3/31/2018	44	3	N/A	8	N/A
12/31/2017	41	3	N/A	8	N/A
9/30/2017	39	3	N/A	9	N/A
6/30/2017	37	4	N/A	9	N/A
3/31/2017	37	3	N/A	10	N/A
12/31/2016	37	3	N/A	12	N/A
9/30/2016	36	3	N/A	9	N/A
6/30/2016	35	2	N/A	7	N/A
3/31/2016	33	3	N/A	6	N/A
12/31/2015	31	3	N/A	5	N/A
9/30/2015	30	3	N/A	6	N/A
6/30/2015	29	4	N/A	7	N/A
3/31/2015	29	3	N/A	6	N/A
12/31/2014	28	3	N/A	5	N/A
9/30/2014	29	3	N/A	4	N/A
6/30/2014	29	3	N/A	3	N/A
3/31/2014	30	4	N/A	4	N/A
12/31/2013	31	5	N/A	4	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (18.3% al año) de SAG es superior a la tasa de ahorro (2.1%).

Beneficios vs. Mercado: Se prevé que los beneficios (18.3% al año) de SAG crezcan más rápidamente que el mercado UK (14.6% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de SAG crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (1.6% al año) de SAG crezcan más despacio que el mercado de UK (3.5% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 1.6% al año) de SAG crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de SAG se prevé que sea elevada dentro de 3 años.

Science Group Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 9.1% to UK£6.35

Price target increased to UK£5.82

Price target increased to UK£5.82

Price target increased to UK£5.61

Science Group plc Provides Revenue Guidance for the Full Year Ended December 31, 2021

Price target increased to UK£5.11

Recent updates

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,570,200 shares, representing 10% of its issued share capital, under the authorization approved on June 18, 2024.

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,570,200 shares, representing 10% of its issued share capital, under the authorization approved on June 18, 2024.

First half 2024 earnings released: EPS: UK£0.13 (vs UK£0.12 in 1H 2023)

Upcoming dividend of UK£0.08 per share

Group MD & Director recently sold UK£333k worth of stock

Science Group plc, Annual General Meeting, Jun 18, 2024

Price target increased by 9.1% to UK£6.35

Science Group plc Proposes Final Dividend for 2023, Payable on 19 July 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Science Group plc to Report Fiscal Year 2023 Results on Mar 21, 2024

New minor risk - Financial data availability

New major risk - Revenue and earnings growth

Group MD & Director exercised options and sold UK£1.2m worth of stock

First half 2023 earnings released: EPS: UK£0.12 (vs UK£0.10 in 1H 2022)

Science Group plc (AIM:SAG) commences an Equity Buyback for 4,537,134 shares, representing 10.01% of its issued share capital, , under the authorization approved on May 18, 2023.

Less than half of directors are independent

Science Group plc Approves Final Dividend

Upcoming dividend of UK£0.05 per share at 1.2% yield

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased to UK£5.82

Science Group plc (AIM:SAG) signed a letter of intent to acquire remaining stakes in TP Group plc (AIM:TPG) from Hargreave Hale Limited, Asset Management Arm for approximately £17.53 million.

Price target increased to UK£5.82

First half 2022 earnings released: EPS: UK£0.10 (vs UK£0.11 in 1H 2021)

Science Group plc to Report First Half, 2022 Results on Jul 25, 2022

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,551,046 shares, representing 10% of its issued share capital, under the authorization approved on May 18, 2022.

Science Group plc Intends to Appoint Susan Clement Davies to the Board as a Non-Executive Director

Upcoming dividend of UK£0.05 per share

Less than half of directors are independent

An Intrinsic Calculation For Science Group plc (LON:SAG) Suggests It's 30% Undervalued

Investor sentiment improved over the past week

Science Group plc Appoints Jon Brett as Finance Director, Effective 1 March 2022

Price target increased to UK£5.61

Science Group plc Provides Revenue Guidance for the Full Year Ended December 31, 2021

Science Group plc (AIM:SAG) commences an Equity Buyback Plan for 4,123,839 shares, representing 9.8% of its issued share capital, under the authorization approved on May 19, 2021.

Executive Chairman recently sold UK£9.0m worth of stock

Science Group plc has completed a Follow-on Equity Offering in the amount of £18.557276 million.

First half 2021 earnings released: EPS UK£0.11 (vs UK£0.048 in 1H 2020)

Price target increased to UK£5.11

Science Group plc Provides Revenue Guidance for the Six Months to 30 June 2021

Is It Time To Consider Buying Science Group plc (LON:SAG)?

Science Group plc Approves Final Dividend

Upcoming dividend of UK£0.04 per share

Science Group (LON:SAG) Has A Pretty Healthy Balance Sheet

Statutory Profit Doesn't Reflect How Good Science Group's (LON:SAG) Earnings Are

Has Science Group plc's (LON:SAG) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.041 loss in FY 2019)

Revenue beats expectations

Shareholders Of Science Group (LON:SAG) Must Be Happy With Their 172% Total Return

Science Group plc Announces Executive Changes

New 90-day high: UK£2.90

Is Science Group (LON:SAG) Using Too Much Debt?

New 90-day high: UK£2.68

Executive Chairman recently sold UK£4.8m worth of stock

Upcoming Dividend of UK£0.02 Per Share

New 90-day high - UK£2.58

New 90-day high - UK£2.43

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento